The global Pharma Ophthalmic market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pharma Ophthalmic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Pharma Ophthalmic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Pharma Ophthalmic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Pharma Ophthalmic include Novartis, Allergan, Roche, Valeant, Regeneron, Santen, Bayer, Pfizer and Senju, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Pharma Ophthalmic, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pharma Ophthalmic, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pharma Ophthalmic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharma Ophthalmic sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pharma Ophthalmic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pharma Ophthalmic sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Allergan, Roche, Valeant, Regeneron, Santen, Bayer, Pfizer and Senju, etc.
By Company
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
Segment by Type
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
Segment by Application
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharma Ophthalmic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pharma Ophthalmic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Ophthalmic sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Pharma Ophthalmic Product Introduction
1.2 Market by Type
1.2.1 Global Pharma Ophthalmic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Retinal disorders drugs
1.2.3 Allergic, inflammatory and infective drugs
1.2.4 Glaucoma drugs
1.2.5 Dry eye drugs
1.2.6 Other ophthalmic drugs
1.3 Market by Application
1.3.1 Global Pharma Ophthalmic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Glaucoma
1.3.3 Dry eye syndrome
1.3.4 Retinal diseases
1.3.5 Other ophthalmic indications
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharma Ophthalmic Sales Estimates and Forecasts 2018-2029
2.2 Global Pharma Ophthalmic Revenue by Region
2.2.1 Global Pharma Ophthalmic Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pharma Ophthalmic Revenue by Region (2018-2023)
2.2.3 Global Pharma Ophthalmic Revenue by Region (2024-2029)
2.2.4 Global Pharma Ophthalmic Revenue Market Share by Region (2018-2029)
2.3 Global Pharma Ophthalmic Sales Estimates and Forecasts 2018-2029
2.4 Global Pharma Ophthalmic Sales by Region
2.4.1 Global Pharma Ophthalmic Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pharma Ophthalmic Sales by Region (2018-2023)
2.4.3 Global Pharma Ophthalmic Sales by Region (2024-2029)
2.4.4 Global Pharma Ophthalmic Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pharma Ophthalmic Sales by Manufacturers
3.1.1 Global Pharma Ophthalmic Sales by Manufacturers (2018-2023)
3.1.2 Global Pharma Ophthalmic Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma Ophthalmic in 2022
3.2 Global Pharma Ophthalmic Revenue by Manufacturers
3.2.1 Global Pharma Ophthalmic Revenue by Manufacturers (2018-2023)
3.2.2 Global Pharma Ophthalmic Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pharma Ophthalmic Revenue in 2022
3.3 Global Key Players of Pharma Ophthalmic, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pharma Ophthalmic Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharma Ophthalmic, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharma Ophthalmic, Product Offered and Application
3.8 Global Key Manufacturers of Pharma Ophthalmic, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharma Ophthalmic Sales by Type
4.1.1 Global Pharma Ophthalmic Historical Sales by Type (2018-2023)
4.1.2 Global Pharma Ophthalmic Forecasted Sales by Type (2024-2029)
4.1.3 Global Pharma Ophthalmic Sales Market Share by Type (2018-2029)
4.2 Global Pharma Ophthalmic Revenue by Type
4.2.1 Global Pharma Ophthalmic Historical Revenue by Type (2018-2023)
4.2.2 Global Pharma Ophthalmic Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pharma Ophthalmic Revenue Market Share by Type (2018-2029)
4.3 Global Pharma Ophthalmic Price by Type
4.3.1 Global Pharma Ophthalmic Price by Type (2018-2023)
4.3.2 Global Pharma Ophthalmic Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pharma Ophthalmic Sales by Application
5.1.1 Global Pharma Ophthalmic Historical Sales by Application (2018-2023)
5.1.2 Global Pharma Ophthalmic Forecasted Sales by Application (2024-2029)
5.1.3 Global Pharma Ophthalmic Sales Market Share by Application (2018-2029)
5.2 Global Pharma Ophthalmic Revenue by Application
5.2.1 Global Pharma Ophthalmic Historical Revenue by Application (2018-2023)
5.2.2 Global Pharma Ophthalmic Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pharma Ophthalmic Revenue Market Share by Application (2018-2029)
5.3 Global Pharma Ophthalmic Price by Application
5.3.1 Global Pharma Ophthalmic Price by Application (2018-2023)
5.3.2 Global Pharma Ophthalmic Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pharma Ophthalmic Market Size by Type
6.1.1 US & Canada Pharma Ophthalmic Sales by Type (2018-2029)
6.1.2 US & Canada Pharma Ophthalmic Revenue by Type (2018-2029)
6.2 US & Canada Pharma Ophthalmic Market Size by Application
6.2.1 US & Canada Pharma Ophthalmic Sales by Application (2018-2029)
6.2.2 US & Canada Pharma Ophthalmic Revenue by Application (2018-2029)
6.3 US & Canada Pharma Ophthalmic Market Size by Country
6.3.1 US & Canada Pharma Ophthalmic Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pharma Ophthalmic Sales by Country (2018-2029)
6.3.3 US & Canada Pharma Ophthalmic Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pharma Ophthalmic Market Size by Type
7.1.1 Europe Pharma Ophthalmic Sales by Type (2018-2029)
7.1.2 Europe Pharma Ophthalmic Revenue by Type (2018-2029)
7.2 Europe Pharma Ophthalmic Market Size by Application
7.2.1 Europe Pharma Ophthalmic Sales by Application (2018-2029)
7.2.2 Europe Pharma Ophthalmic Revenue by Application (2018-2029)
7.3 Europe Pharma Ophthalmic Market Size by Country
7.3.1 Europe Pharma Ophthalmic Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pharma Ophthalmic Sales by Country (2018-2029)
7.3.3 Europe Pharma Ophthalmic Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pharma Ophthalmic Market Size
8.1.1 China Pharma Ophthalmic Sales (2018-2029)
8.1.2 China Pharma Ophthalmic Revenue (2018-2029)
8.2 China Pharma Ophthalmic Market Size by Application
8.2.1 China Pharma Ophthalmic Sales by Application (2018-2029)
8.2.2 China Pharma Ophthalmic Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pharma Ophthalmic Market Size by Type
9.1.1 Asia Pharma Ophthalmic Sales by Type (2018-2029)
9.1.2 Asia Pharma Ophthalmic Revenue by Type (2018-2029)
9.2 Asia Pharma Ophthalmic Market Size by Application
9.2.1 Asia Pharma Ophthalmic Sales by Application (2018-2029)
9.2.2 Asia Pharma Ophthalmic Revenue by Application (2018-2029)
9.3 Asia Pharma Ophthalmic Sales by Region
9.3.1 Asia Pharma Ophthalmic Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pharma Ophthalmic Revenue by Region (2018-2029)
9.3.3 Asia Pharma Ophthalmic Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharma Ophthalmic Market Size by Type
10.1.1 Middle East, Africa and Latin America Pharma Ophthalmic Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pharma Ophthalmic Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pharma Ophthalmic Market Size by Application
10.2.1 Middle East, Africa and Latin America Pharma Ophthalmic Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pharma Ophthalmic Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pharma Ophthalmic Sales by Country
10.3.1 Middle East, Africa and Latin America Pharma Ophthalmic Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pharma Ophthalmic Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pharma Ophthalmic Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Novartis Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Overview
11.2.3 Allergan Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Allergan Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Roche Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Valeant
11.4.1 Valeant Company Information
11.4.2 Valeant Overview
11.4.3 Valeant Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Valeant Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Valeant Recent Developments
11.5 Regeneron
11.5.1 Regeneron Company Information
11.5.2 Regeneron Overview
11.5.3 Regeneron Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Regeneron Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Regeneron Recent Developments
11.6 Santen
11.6.1 Santen Company Information
11.6.2 Santen Overview
11.6.3 Santen Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Santen Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Santen Recent Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Overview
11.7.3 Bayer Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Bayer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Pfizer Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Senju
11.9.1 Senju Company Information
11.9.2 Senju Overview
11.9.3 Senju Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Senju Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Senju Recent Developments
11.10 Akorn
11.10.1 Akorn Company Information
11.10.2 Akorn Overview
11.10.3 Akorn Pharma Ophthalmic Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Akorn Pharma Ophthalmic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Akorn Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharma Ophthalmic Industry Chain Analysis
12.2 Pharma Ophthalmic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharma Ophthalmic Production Mode & Process
12.4 Pharma Ophthalmic Sales and Marketing
12.4.1 Pharma Ophthalmic Sales Channels
12.4.2 Pharma Ophthalmic Distributors
12.5 Pharma Ophthalmic Customers
13 Market Dynamics
13.1 Pharma Ophthalmic Industry Trends
13.2 Pharma Ophthalmic Market Drivers
13.3 Pharma Ophthalmic Market Challenges
13.4 Pharma Ophthalmic Market Restraints
14 Key Findings in The Global Pharma Ophthalmic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
听
听
*If Applicable.